Invention Grant
- Patent Title: Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
-
Application No.: US16478966Application Date: 2018-01-19
-
Publication No.: US10550153B2Publication Date: 2020-02-04
- Inventor: Yoshio Hayashi , Kentaro Takayama , Mikiya Miyazato , Kenji Kangawa , Kenji Mori , Akira Yamamoto , Toshiyasu Sakane
- Applicant: Tokyo University of Pharmacy & Life Sciences , National Cerebral and Cardiovascular Center , Kyoto Pharmaceutical University
- Applicant Address: JP Tokyo JP Osaka JP Kyoto
- Assignee: TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES,NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER,KYOTO PHARMACEUTICAL UNIVERSITY
- Current Assignee: TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES,NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER,KYOTO PHARMACEUTICAL UNIVERSITY
- Current Assignee Address: JP Tokyo JP Osaka JP Kyoto
- Agency: Lucas & Mercanti, LLP
- Priority: JP2017-008301 20170120
- International Application: PCT/JP2018/001651 WO 20180119
- International Announcement: WO2018/135641 WO 20180726
- Main IPC: A61K38/03
- IPC: A61K38/03 ; C07K7/06 ; A61P3/04 ; A61K38/00
Abstract:
To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
Public/Granted literature
- US20190359652A1 PEPTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR PRODRUG THEREOF Public/Granted day:2019-11-28
Information query
IPC分类:
